JAM Capital Partners

• Our partners do not have an artificial time horizon – we can be your partner for the long haul
• We are willing to co-invest alongside other firms
• We primarily seek growth equity investments where we can invest alongside management teams though we are open to recapitalizations / buyouts on a case by case basis
• Our typical investment will range from $4M to $10M though we can go larger or smaller

FOR INVESTORS / BUSINESS OWNERS

• Our partnership is comprised of successful entrepreneurs and families who seek to invest alongside management teams with values and operating methods that align with those of our partners
• In addition to growth capital, our investment partners bring a wealth of experience and business relationships to bear for the benefit of our portfolio companies
• We welcome the opportunity to meet entrepreneurial families and individuals who share our collaborative approach to investing High Performance Product Engineering (HPPE) produces the next generation of high performance and cost competitive biopolymer based products for a variety of industrial markets and serves customers in the oil and gas market, pharma, mining, water industries We invested in HPPE in 2015 and have continued to invest in the company to support its rapid growth and expansion of its manufacturing capabilities

Vivex is a regenerative medicine business located in Atlanta and Miami We invested in Vivex when it was spun out of its sister company Amendia and have continued to invest in the business to support its rapid growth and product development plans

Brand Bank, chartered in 1905, is a fast growing community bank serving the Atlanta market We invested in Brand Bank in 2011 as a part of a $200M recapitalization of the bank alongside the Carlyle Group, The Stephens Group and Nonami Enterprises

Barry’s is a leading high intensity fitness company headquartered in Los Angeles, CA with stores in key markets on both coasts We invested in Barry’s alongside a leading private equity firm in a recapitalization in 2015

AxoGen (NASDAQ: AXGN) is regenerative medicine business that is a global leader in innovative surgical solutions for peripheral nerve injuries We invested in AxoGen in 2010 and exited via a merger and subsequent public listing on the NASDAQ in 2013

Gila is a leading nationwide provider of accounts receivables management (“ARM”) and business process outsourcing solutions to governmental entities and credit unions We exited the Gila investment in 2015 when the business was sold to Navient (NASDAQ: NAVI)

Mr McCallum founded JAM Capital Partners in 2010 and serves as Managing Partner overseeing all aspects of the firm

Chris is a Vice President with JAM Capital Partners and leads underwriting, diligence and investment execution

Mr Cummings backed John McCallum to launch JAM Capital Partners in 2010 and remains active in the leadership of the firm as an investor and operating partner

Mr Rogers is an active investor with JAM Capital Partners and serves as Chairman of Rogers Electric, a nationwide electrical contracting and engineering firm

Former U S House Speaker Gingrich works with JAM Capital Partners on business development and portfolio company activities

Case Studies Highlighting Our Creative Approach to Working with Entrepreneurs.

Regenerative medicine and biomaterials located in Atlanta, GA and Miami, FL

Innovative biochemical business based in Columbus, GA

Leading provider of innovative medical devices used in spinal surgical procedures

Regenerative medicine company headquartered in Alachua, FL